Vaccine volatility – what have investors done?
- Global, South Africa
-
American Airlines, Aspen, Carnival Corporation, Gold, Netflix, Pfizer, Sasol, TripAdvisor, Vaccine, Zoom
- November 9, 2020
Today was a monumental day on the markets. Pfizer announced that its Covid-19 vaccine has been found to be 90% effective, comfortably the most important scientific breakthrough thus far in the fight against the virus. Now, your immediate reaction might be to buy Pfizer shares. Funnily enough, at time of writing, Pfizer was only up 6% after the news. That …
View Post
Aspen gives South Africa a booster shot
Despite the negative cloud that we typically find ourselves under in South Africa, we still boast world-class technology and manufacturing capabilities in a number of industries. Aspen Pharmacare has had a really tough few years on the JSE, having struggled with a debt-funded globalisation strategy that hasn’t worked out. However, the market cheered the news that Aspen has entered into …
View Post
Aspen prescribes bolt-on acquisitions
Aspen Pharmacare is a R60bn pharmaceuticals giant that used to be a lot bigger. The share price is down over 57% in 5 years, reflecting an unsuccessful strategy to push into developed as well as emerging markets, all while steadily building up a debt pile. It’s a story that seems to play out over and over again: South African corporates …
View Post